RYTM - Rhythm Pharmaceuticals GAAP EPS of -$0.85 beats by $0.06 revenue of $1.82M beats by $0.12M March, 01 2022 07:14 AM Rhythm Pharmaceuticals Inc. Rhythm Pharmaceuticals press release (NASDAQ:RYTM): Q4 GAAP EPS of -$0.85 beats by $0.06. Revenue of $1.82M beats by $0.12M. For further details see: Rhythm Pharmaceuticals GAAP EPS of -$0.85 beats by $0.06, revenue of $1.82M beats by $0.12M